Repression of the interferon signal transduction pathway by the adenovirus E1A oncogene.

AUTOR(ES)

Gutch, M J

RESUMO

The signal transduction pathway initiated by type I interferon (alpha and beta interferons) is inhibited by expression of the adenovirus type 5 E1A oncogene. Cotransfection analyses with the E1A oncogene and an interferon-stimulated reporter gene show that mutations within an amino-terminal domain of the E1A oncoprotein are defective in transcriptional repression. Cotransfection experiments also revealed that the transcriptional repression is mediated through the interferon-stimulated response element (ISRE) found within the promoter of interferon-stimulated genes. Since interferon treatment activates a latent cytoplasmic DNA-binding factor that can recognize the ISRE and subsequently stimulate transcription, the appearance of this factor was analyzed in a cell line that constitutively expresses the E1A oncogene. The DNA binding activity of this transcriptional activator was found to be inhibited in the E1A-expressing cell line. In vitro cytoplasmic mixing experiments with extracts from control and E1A-expressing cells identified a specific component of this multimeric transcription factor to be defective.

Documentos Relacionados

• Database of mutations within the adenovirus 5 E1A oncogene.
• Inhibition of the cellular response to interferons by products of the adenovirus type 5 E1A oncogene.
• Interactions between cell growth-regulating domains in the products of the adenovirus E1A oncogene.
• Adenovirus type 5 E1A gene products act as transformation suppressors of the neu oncogene.
• Different activities of the adenovirus types 5 and 12 E1A regions in transformation with the EJ Ha-ras oncogene.